Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy‐induced anaemia: An observational, retrospective, monocentric analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|36|1|136-143

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 136-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epoetin- cost effective for chemotherapy-induced anaemia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 245, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Epoetin alfa cost effective in chemotherapy-induced anaemia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Epoetin alfa cost effective in chemotherapy-induced anaemia

By  

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of chemotherapy-induced anaemia

By Vansteenkiste Johan  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2221-2227

Informa Healthcare

Access to resources Recommend Favorite

Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia: Evidence from a 16-Week Randomised Trial

By Reed Shelby D.   Radeva Jasmina I.  

PharmacoEconomics, Vol. 24, Iss. 5, 2006-01 ,pp. : 479-494

Adis International

Access to resources Recommend Favorite